Compare GRFS & GTES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRFS | GTES |
|---|---|---|
| Founded | 1940 | 1911 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 5.6B |
| IPO Year | 2006 | 2018 |
| Metric | GRFS | GTES |
|---|---|---|
| Price | $8.87 | $22.80 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $10.15 | ★ $26.67 |
| AVG Volume (30 Days) | 485.7K | ★ 1.7M |
| Earning Date | 07-28-2022 | 02-05-2026 |
| Dividend Yield | ★ 1.60% | N/A |
| EPS Growth | N/A | ★ 9.34 |
| EPS | 0.64 | ★ 0.91 |
| Revenue | ★ $8,821,017,248.00 | $3,416,400,000.00 |
| Revenue This Year | $5.36 | $3.02 |
| Revenue Next Year | $5.15 | $3.33 |
| P/E Ratio | ★ $17.46 | $25.02 |
| Revenue Growth | ★ 7.31 | N/A |
| 52 Week Low | $6.19 | $14.70 |
| 52 Week High | $11.14 | $26.46 |
| Indicator | GRFS | GTES |
|---|---|---|
| Relative Strength Index (RSI) | 44.66 | 55.10 |
| Support Level | $8.79 | $22.21 |
| Resistance Level | $9.40 | $23.20 |
| Average True Range (ATR) | 0.24 | 0.63 |
| MACD | -0.05 | 0.11 |
| Stochastic Oscillator | 12.18 | 77.09 |
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Gates Industrial Corp PLC is a manufacturer of engineered power transmission and fluid power solutions. The company has two operating segments; Power Transmission and Fluid Power segments. The Power Transmission solutions convey power and control motion. It is used in applications in which belts, chains, cables, geared transmissions, or direct drives transfer power from an engine or motor to another part or system. The Fluid power solutions are used in applications in which hoses and rigid tubing assemblies either transfer power hydraulically or convey fluids, gases, or granular materials from one location to another. The company generates key revenue from the Power Transmission segment. Company operates in USA, United Kingdom, Luxembourg, EMEA, with majority revenue from USA.